In ex vivo human pancreatic cancer specimens, RT-induced IL-8 effectively recruits unmodified natural killer (NK) cells, demonstrating a synergistic potential for combining radiation therapy with NK cell-based treatments to enhance cancer therapy outcomes [72]. Here, CXCL8 is linked to familial pancreatic carcinoma.